12th week of 2011 patent applcation highlights part 28 |
Patent application number | Title | Published |
20110070266 | IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS - The invention relates to immunogenic compositions comprising combinations of | 2011-03-24 |
20110070267 | PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE - The invention relates to the finding that virus like particles (VLPs) can be loaded and packaged, respectively, with DNA oligonucleotides rich in non-methylated C and G (CpGs). If such CpG-VLPs are mixed with antigens, the immunogenicity of these antigens are dramatically enhanced. In addition, the T cell responses against the antigens are especially directed to the Th1 type. Surprisingly, no covalent linkage of the antigen to the VLP is required; it is sufficient to simply mix the VLPs with the adjuvants for co-administration. In addition, it was found that VLPs did not enhance immune responses unless they were loaded and packaged, respectively, with CpGs. Antigens mixed with CpG-packaged VLPs may therefore be ideal vaccines for prophylactic or therapeutic vaccination against allergies, tumors and other self-molecules and chronic viral diseases. | 2011-03-24 |
20110070268 | Method - Methods for characterisation of patients as responders or non-responders to therapy based on differential expression of one or more genes are provided. Gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles, and new diagnostic kits and methods of treatment are also provided. The kits and methods relate to the treatment of specific populations of, for example, cancer patients, as characterised by their gene expression profile, suffering from MAGE expressing tumours. | 2011-03-24 |
20110070269 | LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF - This disclosure provides, in certain embodiments, methods for generating and using extracts of | 2011-03-24 |
20110070270 | IMMUNOSTIMULATING AGENT - An immunostimulating agent, which can stimulate immunity effectively, is described. The immunostimulating agent contains an active ingredient including a calcium receptor activator such as γ-Glu-X-Gly [wherein X represents an amino acid or a derivative thereof other than Cys], γ-Glu-Val-Y [wherein Y represents an amino acid or a derivative thereof], γ-Glu-Ala, γ-Glu-Gly, γ-Glu-Met, γ-Glu-Thr, γ-Glu-Val, γ-Glu-Orn, Asp-Gly, Cys-Gly, Cys-Met, Glu-Cys, Gly-Cys, Leu-Asp, γ-Glu-Met(O), γ-Glu-γ-Glu-Val, γ-Glu-Val-NH2, γ-Glu-Val-ol, γ-Glu-Ser, γ-Glu-Tau, γ-Glu-Cys(S-Me)(O), γ-Glu-Leu, γ-Glu-Ile, γ-Glu-t-Leu, γ-Glu-Cys(S-Me), a cation having a valency of 2 or more, protamine, polylysine, spermine, spermidine, putrescine, cinacalcet, a cinacalcet analogue compound, and a salt of any one of the aforementioned components. | 2011-03-24 |
20110070271 | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles - Constructs that are at least partially constructed of allograft cancellous bone are disclosed, along with cartilage particles that may be used with the constructs for repairing articular cartilage defects. A multi-piece construct includes a base member, a cap member and at least one pin that secures the cap member to the base member. The base member may be constructed of mineralized cancellous bone, and is used to replace the subchondral bone removed when a surgeon cuts a bore in the area of an adjacent cartilage defect. The base member includes a blind bore and first and second through-going transverse bores in opposite sides of a wall of the base member. The cap member includes an upper section that has a thickness that is similar to that of a patient's surrounding articular cartilage layer and a stem depending from the upper section that is dimensioned to be received in and by the blind bore of the base member. The stem includes a transverse through-going bore, which may be aligned with the transverse through-going bores of the base member to receive the pin therein when the construct has been assembled. The cap member is at least partially formed of demineralized allograft cancellous bone, into which a mixture containing lyophilized, freeze-milled allograft cartilage particles may be infused for the repair of articular cartilage defects. The cartilage particles have a size within a range of from about 10 microns to about 210 microns. | 2011-03-24 |
20110070272 | Materials and Methods for Modulating Metabolism - The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications. | 2011-03-24 |
20110070273 | High-Coverage and Natural-Looking Cosmetic Compositions and Uses Thereof - Topical compositions comprising at least one matte-finished interference pigment combined with one or more microsphere(s) and elastomer(s) are provided, as well as methods for using such compositions in cosmetics and dermatological products that afford high coverage of flaws or imperfections, while maintaining a natural-looking appearance. These cosmetics and dermatological products can improve the aesthetic appearance of skin, hair, or nails when topically applied thereto. | 2011-03-24 |
20110070274 | DERMATOLOGICAL/COSMETIC GELS COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE - Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor. | 2011-03-24 |
20110070275 | CRYSTALLINE PYRITHIONE/ZINC OXIDE COMPOSITE AND PHYSIOLOGIC/ANTIBIOTIC COMPOSITION CONTAINING THE SAME - Although zinc pyrithione is known as an excellent antidandruff component, there is a demand for an effort to reduce the blending amount without lowering the effects from the viewpoint of environmental pollution. Also, there is a demand for developing a technique that enables combining zinc pyrithione with cuprous oxide to be used as an antifouling component for a ship-bottom paint. Moreover, also as an antiseptic and anti-mold component for polymer materials, further enhancement of the antimicrobial activity of zinc pyrithione has been demanded. | 2011-03-24 |
20110070276 | BIOACTIVE KERATIN PEPTIDES - Compositions containing biologically active peptides are disclosed. Active peptides are isolated fragments derived from human hair or sheep wool keratin proteins. Compositions may be prepared for pharmaceutical or topical administration or for use in cosmetic preparations. | 2011-03-24 |
20110070277 | Substrate Comprising A Lotion Composition Limiting the Adherence of Feces or Menses to the Skin - A lotion composition applied on the body facing surface of an absorbent article such as a diaper, training pant, adult incontinence product, feminine hygiene product, improves the ease of removal of feces or menses after an absorbent article comprising the lotion composition has been used and removed from the wearer. The lotion composition may also suitably be applied on a wipe. | 2011-03-24 |
20110070278 | METCONAZOLE COMPOSITIONS AND METHODS OF USE - The invention generally relates to fungicidal non-aqueous, dispersible concentrate (DC) compositions comprising metconazole, non-ionic surfactants, and solvents. Methods of use and ready-to-use products are also provided. | 2011-03-24 |
20110070279 | Anti-bug fabric - An anti-bug fabric is a flat piece of fabric and composed of multiple longitudinal strings and multiple altitude strings which are weaved to the longitudinal strings. Each of the longitudinal strings and altitude strings includes an inner portion and an outer portion which wraps to the inner portion, wherein the inner portion is composed of multiple wires and the outer portion is made plastic material mixed with anti-bug material. | 2011-03-24 |
20110070280 | METHOD FOR DIFFERENTIATING EMBRYONIC STEM CELLS INTO CELLS EXPRESSING AQP-1 - The present invention relates to methods of differentiating a human embryonic stem (ES) cell into a cell, specifically a renal epithelial cell, expressing AQP-I. The methods disclosed comprise culturing human ES cells in a renal specific medium in the presence of an extracellular matrix molecule. The cells produced according to said method can be used to treat renal related disorders such as renal failure, nephrosis, Bright's disease and glomerulitis. | 2011-03-24 |
20110070281 | REPARATIVE CELL DELIVERY VIA HYALURONIC ACID VEHICLES - Methods are described for generating autologous tissue grafts, including generating grafts at the point of case, which include isolated cell populations that are enriched with stem cells and are mixed with hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft. | 2011-03-24 |
20110070282 | Materials and Methods for Treating Skeletal System Damage and Promoting Skeletal System Repair and Regeneration - Disclosed herein are materials and methods suitable for treating injured, damaged or diseased mineralized and non-mineralized skeletal tissues, including bones, joints, tendons, ligaments, cartilage and/or other non-mineralized skeletal tissues. The affected structure can be treated by contacting a surface of the skeletal element at or adjacent to or in the vicinity of an area of injury, damage or disease with an implantable material. The implantable material comprises a biocompatible matrix and cells and is in an amount effective to treat the affected structure. A composition comprising a biocompatible matrix and cells engrafted therein or thereon can be used to treat the affected structure. The composition can be a flexible planar material or a flowable composition. | 2011-03-24 |
20110070283 | Coating For Implantable Devices And A Method Of Forming The Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 2011-03-24 |
20110070284 | BIOLOGIC MATRICES COMPRISING ANTI-INFECTIVE METHODS AND COMPOSITIONS RELATED THERETO - Described herein are methods and compositions related to biologic matrices comprising at least one anti-infective. In certain embodiments, the invention relates to a biologic matrix comprising a slowed release anti-infective agent. In a particular embodiment, the invention relates to an acellular dermal matrix comprising a slowed release antiinfective agent, wherein the anti-infective agent is triclosan. In further embodiments, the the biologic matrix is suitable for use in surgical procedures, such as, for example, for the replacement of damaged or inadequate integumental tissue or for the repair, reinforcement or supplemental support of soft tissue defects. | 2011-03-24 |
20110070285 | METHOD OF MAKING FLEXIBLE BIORESORBABLE HEMOSTATIC PACKING AND STENT HAVING A PRESELECTABLE IN-VIVO RESIDENCE TIME - The invention provides a method of making flexible bioresorbable foam having hemostatic properties and a preselectable in-vivo residence time. A blend of crosslinked collagen blended and a hyaluronic acid component is prepared. The blend is mixed with water to form a suspension. The blend is freezed and lyophilized at less than about 0° C. Next, the blend is crosslinked. The product is then sterilized and chain scission is performed by bombardment with gamma rays or a beam of electrons. | 2011-03-24 |
20110070286 | PROCESS FOR THE MANUFACTURE OF NICOTINE-COMPRISING CHEWING GUM AND NICOTINE-COMPRISING CHEWING GUM MANUFACTURED ACCORDING TO SAID PROCESS - A process for making a nicotine-comprising chewing gum by (i) dispensing a powder portion from a gum-base-comprising powder, (ii) optionally shaping said powder portion into a powder aggregate, and (iii) applying sufficient electromagnetic energy (EM energy) to said powder portion or said powder aggregate to transform said powder portion or said powder aggregate into said chewing gum, whereby said EM energy is Radio Frequency (RF) energy, MicroWave (MW) energy, InfraRed (IR) energy or UltraViolet (UV) energy or combinations thereof. The invention also features a chewing gum made by such process. The chewing gum may comprise one or more deposits. | 2011-03-24 |
20110070287 | Film-Coated Compressed Chewing Gum - A compressed chewing gum tablet includes at least one compressed chewing gum module, the at least one compressed chewing gum module including a compressed particulate chewing gum composition, which compressed particulate chewing gum composition includes compressed chewing gum particles containing gum base. The content of gum base is at least 5% by weight of the tablet, the chewing gum tablet is provided with a film coating, and the film coating includes liquid flavoring. | 2011-03-24 |
20110070288 | COMPOSITE LAYERED HEMOSTASIS DEVICE - The present invention is directed to a hemostatic composite structure having a bioabsorbable fabric or non-woven substrate having at least two major oppositely facing surface areas and a continuous non-porous polymer-based film that is laminated on one major surface of said substrate. The bioabsorbable fabric substrate can be an oxidized polysaccharide and/or the non-woven substrate can be made from bioabsorbable, non-cellulosic derived polymers. The continuous non-porous polymer based film can be a bioabsorbable polymer. The present invention also relates to a method for providing hemostasis by applying a composite structure described herein onto a wound site in need of a hemostatic device wherein a major surface of the substrate without the film layer is applied onto the wound site. | 2011-03-24 |
20110070289 | ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER MODIFIED MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES - Diabetes mellitus is a disease of elevated blood glucose, often directly related to a deficiency in insulin production or insulin receptor production. The innovative strategy of treatment described here utilizes modified viruses and virus-like vehicles to act as a transport mechanism to deliver modified messenger RNA molecules to target cells in the body. Delivering to the Beta cells in the body the modified messenger RNA needed to construction of insulin or insulin receptors will lead to enhanced production of biologically active insulin or insulin receptors by Beta cells as necessary, which will lead to correcting deficiencies in insulin or insulin receptors the result of which will help properly regulate blood glucose levels throughout the body utilizing innate regulatory mechanisms. | 2011-03-24 |
20110070290 | VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT - Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous form. Chemically defined, synthetic GLA offers a consistent vaccine component from lot to lot without the fluctuations in contaminants or activity that compromise natural-product adjuvants. Also provided are vaccines and pharmaceutical compositions that include GLA and one or more of an antigen, a Toll-like receptor (TLR) agonist, a co-adjuvant and a carrier such as a pharmaceutical carrier. | 2011-03-24 |
20110070291 | FOOD OR BEVERAGE COMPOSITION FORTIFIED WITH THYRONAMINES AND/OR THYRONAMINE PRECURSORS - Food or beverage compositions fortified with thyronines and/or thyronamines, processes for increasing T2, T1AM, and/or T0AM in a subject by administering a food or beverage composition that is fortified with at least one thyronine and/or thyronamine compound, and processes for promoting a healthy state by administering a food or beverage composition to a subject that is fortified with at least one thyronine and/or thyronamine compound. Increased levels of T2, T1AM, and/or T0AM in a subject can be associated with at least one of healthy cholesterol levels, healthy triglyceride levels, healthy blood sugar levels, cardiovascular health, healthy sleep patterns, healthy mood, healthy skin, healthy nails, or healthy endocrine function and/or a number of other markers of associated with general health and well-being. | 2011-03-24 |
20110070292 | Methods For The Preparation Of Liposomes - Provided herein are methods for preparing liposomes and uses thereof. In certain embodiments, liposomes are prepared without using heat, organic solvents, proteins, and/or inorganic salts in the process. In certain embodiments, the liposomal preparation contains one or more active agents. In certain embodiments, the liposomal preparations are used in the treatment of diseases or disorders. | 2011-03-24 |
20110070293 | Methods for the Preparation of Liposomes Comprising Docetaxel - Provided herein are methods for preparing liposomes comprising docetaxel and uses thereof. In certain embodiments, liposomes are prepared without using heat, organic solvents, proteins, and/or inorganic salts in the process. In certain embodiments, the liposomal preparations are used in the treatment of diseases or disorders. | 2011-03-24 |
20110070294 | Methods for the Administration of Drugs Using Liposomes - Provided herein are methods for the administration of drugs using liposomes. In particular, provided herein is the use of liposomes as diluents for lyophilized or liquid drugs to deliver the drug safely, reduce the toxicity of the drug or the excipients used to solubilize or stabilize the drug. | 2011-03-24 |
20110070295 | METHODS FOR THE PREPARATION OF LIPOSOMES COMPRISING DOCETAXEL - Provided herein are methods for preparing liposomes comprising docetaxel and uses thereof. In certain embodiments, liposomes are prepared without using heat, organic solvents, proteins, and/or inorganic salts in the process. In certain embodiments, the liposomal preparations are used in the treatment of diseases or disorders. | 2011-03-24 |
20110070296 | TOPICAL COMPOSITIONS AND METHODS FOR UTILIZING PEPTIDES CONTAINING LIPID-MODIFIED CYSTEINE-CONTAINING PEPTIDES - Described are compositions for topical application to keratinous tissues or substrates such as skin, or mucosal surfaces. The composition may be used to treat a skin condition or disease. The composition comprises at least one polypeptide and/or lipidated peptide and a carrier. | 2011-03-24 |
20110070297 | GLUCOKINASE ACTIVATORS - Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of: | 2011-03-24 |
20110070298 | Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance - The invention provides a composition comprising: an antigen; liposomes; a polyI:C polynucleotide; and a carrier comprising a continuous phase of a hydrophobic substance. Methods for making and using the compositions are also provided. | 2011-03-24 |
20110070299 | DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF DULOXETINE - A pharmaceutical composition comprising duloxetine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient(s) characterised in that the duloxetine has a D | 2011-03-24 |
20110070300 | EXTENDED RELEASE DOSAGE FORMS OF METOPROLOL - The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable excipients. The invention also relates to processes for the preparation of an inert core and extended release dosage forms. | 2011-03-24 |
20110070301 | ORALLY TRANSFORMABLE TABLETS - The present invention features a tablet including one or more pharmaceutically active agent(s), one or more thickeners, and one or more binder(s), wherein the tablet includes at least 200 mg of the pharmaceutically active agent(s) and the tablet has been fused with the binder(s) such that the tablet (i) has a water permeation time of less than 60 seconds and (ii) has an in vitro disintegration time of greater than 60 seconds. | 2011-03-24 |
20110070302 | COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION WITH ACCELERATED CONTROLLED ACTIVE SUBSTANCE RELEASE - The present invention relates to pharmaceutical or nutraceutical preparations comprising a) a core containing a pharmaceutically or nutraceutically active substance; and b) a controlling layer surrounding the core comprising
| 2011-03-24 |
20110070303 | NOVEL DOSAGE FORMULATION - The invention relates to a process for preparing a pharmaceutical tablet composition which comprises an active pharmaceutical ingredient of formula I | 2011-03-24 |
20110070304 | MANUFACTURE OF TABLET HAVING IMMEDIATE RELEASE REGION AND SUSTAINED RELEASE REGION - In one aspect, the present invention features a process for making a tablet including a pharmaceutically active agent wherein the tablet has both an immediate release region and a modified release region. The method includes the steps of: (a) forming a tablet shape including a powder blend containing a pharmaceutically active agent and a thermally-sensitive material; and (b) applying energy in different amounts to different regions of the tablet shape to form the tablet in a manner such that: (i) a first region of the tablet shape is exposed to said energy for a sufficient period of time to melt the thermally-sensitive material within the first region to form said modified release region of said tablet; and (ii) a second region of said tablet shape is not so exposed to the energy such that said second region forms the immediate release region of said tablet. | 2011-03-24 |
20110070305 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MEBICAR - The invention relates to a sustained release pharmaceutical composition, containing mebicar, for the treatment of anxiety, depression and other psychiatric and neurological disorders. | 2011-03-24 |
20110070306 | Antimicrobial nanoemulsion compositions and methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 2011-03-24 |
20110070307 | TISSUE REGENERATION - A method including positioning a delivery device at a location in a vessel within a mammalian body, introducing a first treatment agent including a cellular component through the delivery device, and introducing a different second treatment agent disposed in a carrier through the delivery device. A method including identifying an infarct region within myocardial tissue and a border region of perfused tissue adjacent the infarct region, introducing a treatment agent including a cellular component to the border region, and introducing a plurality of microparticles to the infarct region. A kit including a treatment agent including a cellular component in a form suitable for percutaneous delivery, and a separate amount of a plurality of microparticles in a form suitable for percutaneous delivery. | 2011-03-24 |
20110070308 | BED BUG INSECTICIDE - The insecticide comprises an insecticide particularly for killing bed bugs comprising nanospheres and primary ingredients of Organic Andirobia, Orange, Citronella, Organic Neem and Australian Myrtle oils. The insecticide can further comprise Isopropyl Alcohol as a carrier, Phenoxyethanol, Lavandox and Leucojum Aestivum Bulb Extrac. | 2011-03-24 |
20110070309 | PHARMACEUTICAL FORMULATION COMPRISING A WATER-INSOLUBLE ACTIVE AGENT - A method of preparing a pharmaceutical formulation comprises providing a solution comprising a first solvent, a second solvent, an active agent, and an excipient. The second solvent is less polar than the first solvent and the excipient is more soluble in water than the active agent. The first and second solvents are removed from the solution to produce particles comprising the active agent and the excipient. In one version, the excipient comprises an amino acid and/or a phospholipid. A pharmaceutical formulation made by a version of the invention comprises particles comprising an active agent and an excipient which at least partially encapsulates the active agent, wherein the excipient is more soluble in water than the active agent. | 2011-03-24 |
20110070310 | TOPICAL OPHTHALMIC PHARMACEUTICAL FORMULATION OF (2S,3S,4R)-N''-CYANO-N-(6-AMINO-3,4-DIHYDRO-3-HYDROXY-2-METHYL-2-DIMETHOX- YMETHYL-2H-BENZOPYRAN-4-YL)-N'-BENZYLGUANIDINE - A topical ophthalmic pharmaceutical formulation may include particles of the compound (2S,3S,4R)—N″-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine suspended in a solution comprising monobasic sodium phosphate monohydrate, disodium phosphate heptahydrate, edetate disodium, benzalkonium chloride, sodium chloride, polysorbate 80, and water. A method of treating glaucoma may include topically applying to the eye of a patient in need thereof a therapeutically effective amount of this formulation. | 2011-03-24 |
20110070311 | Producing a sustained-release preparation - This invention provides a production method for a solid sustained-release preparation, characterized in that a sustained-release preparation (a sustained-release preparation suspension) is freeze-dried in a freeze-drying container whose inner face is partially or totally coated with an ice layer or water-repelling base material. | 2011-03-24 |
20110070312 | BONE MATRIX COMPOSITIONS AND METHODS - Methods for demineralizing bone are provided. In some embodiments, the methods include demineralizing the bone in a demineralization medium and separating the bone into particles during demineralization. In other embodiments, the methods include placing the bone in a demineralization medium and treating the demineralization medium while the bone is in the demineralization medium to optimize the demineralization process. | 2011-03-24 |
20110070313 | METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS - Disclosed are methods of preparing and using placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a “guided differentiation” program in cancer cells, thereby reducing malignancy. Further extension of the invention pertains to augmenting ability of administered cells to induce differentiation through the co-administration of known differentiation inducing agents. Within the context of this disclosure, methods for inducing host responses to cancer are also described. | 2011-03-24 |
20110070314 | METHODS FOR TREATING BRAIN TUMORS - The present invention relates to methods treating brain tumors comprising administering a subject in need thereof a therapeutically effective amount of sodium meta arsenite, alone or in combination with another anti-brain tumor medicament. | 2011-03-24 |
20110070315 | Composition for the treatment of hair loss and baldness - A synergistic composition, or the use of that composition in the manufacture of a medicament, or a method of treatment including the use of that composition, for the treatment of hair loss and baldness, for combined, sequential or simultaneous administration, in any form, via any biological route. In its optimal embodiment the composition consists, in the form of a lotion: 1600-2400 IU/mL Vitamin A Palmitate, 0.64%-0.96% Thiamine Hydrochloride, 0.64%-0.96% Pyridoxine Hydrochloride, 4.8%-7.2% Niacinamide, 2.85%-5.2% D-Panthenol, 1.6%-2.4% L-Arginine, 3.6%-4.4% Methyl Sulphonyl Methane (MSM), 0.08%-0.12% Ginger Oil, 0.08%-0.12% Cinnamon Oil, 0.0996%-0.1494% Oleoresin Capsicum, 1.3%-1.95% Magnesium, 2.4%-3.6% Zinc, 0.192%-0.288% Manganese, 2.6%-3.9% Urea, 2.4%-3.6% Sodium Glycerophosphate, 4.8%-7.2% L-Lysine HCl, plus Preservatives, Co-solvent (Propylene Glycol), Fragrances, Anti-Oxidant, Cooling agent (Menthol), Emulsifier, and Vehicle (Purified water). | 2011-03-24 |
20110070316 | Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof - The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds. | 2011-03-24 |
20110070317 | PYRROLOPYRIDINES AS KINASE INHIBITORS - Compounds of Formula (I) are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. | 2011-03-24 |
20110070318 | SKIN DRESSINGS - A skin dressing is provided comprising a first component comprising a source of protons, a second component comprising a nitrite salt, the dressing comprising a non-thiol reductant, such that, when the first and second components are brought together and applied to a skin site the nitrite reacts to generate nitric oxide, increasing the pH of the dressing in contact with the skin from an acidic value to a more neutral value. | 2011-03-24 |
20110070319 | BIFEPRUNOX DOSES FOR TREATING SCHIZOPHRENIA - The present disclosure is directed to compositions, kits and methods for not only treating schizophrenia, e.g., maintaining, reducing and/or improving at least one symptom of schizophrenia, but also to achieving an absence of or a reduced presence of at least one side effect associated with schizophrenia therapy with a first-generation atypical antipsychotic. | 2011-03-24 |
20110070320 | BIODEGRADABLE THERMORESPONSIVE 3-ARM POLYETHYLENE GLYCOL POLY(LACTIDE-CO-GLYCOLIDE) COPOLYMER FOR GINSENG ADMINISTRATION - The present invention discloses a composition comprising a ginseng product, a mucoadhesive and a mucosa penetration enhancer in an aqueous biodegradable block copolymer solution consisting of a 3-arm polyethylene glycol (PEG) and 3 polyesters chains, each of which extends on each of the arm of the 3-arm PEG. The invention also provides a method for transmucosal delivery of pharmaceuticals and nutraceutical such as ginsenosides with improved absorption and bioavailability. | 2011-03-24 |
20110070321 | Method and Composition for Cutaneous Treatment of Herpes Simplex Infections - A method for cutaneous treatment of Herpes simplex infections by applying topically to the area of outbreak a composition comprising at least 1% by weight D-Lenolate® olive leaf extract. A composition for treatment is also disclosed, containing, by weight, at least 1% D-Lenolate® olive leaf extract, 1-3% neem, 0.05-1% aloe and 0.05-1% menthol. | 2011-03-24 |
20110070322 | PESTICIDAL COMPOSITIONS CONTAINING ROSEMARY OIL AND WINTERGREEN OIL - Pesticidal compositions containing rosemary oil and/or wintergreen oil and methods for using same are disclosed. | 2011-03-24 |
20110070323 | PEDICULICIDE COMPOSITIONS - A non-toxic, highly effective composition for the elimination of lice and their eggs is provided. The composition contains natural products, namely plant oils, beside harmless cosmetic additives. | 2011-03-24 |
20110070324 | Barrel Clamping System for Quick Assembling and Dismantling of Extruder Barrel Sections - A system for clamping together a pair of extruder barrel sections of an extruder is disclosed. The system comprises of a clamp that includes an upper arm, and a lower arm connected to the upper arm at one edge of the upper arm. The upper and lower arms cooperating to define a recess configured to receive a pair of extruder barrel sections. The clamp further includes a locking structure configured to lock the upper arm to the lower arm with the pair of extruder barrel sections therebetween. The system further comprises of a support structure for the clamp that includes a bracket connected to the clamp and a column connected to a base of the extruder. The bracket and column are connected to each other such that relative movement between the bracket and the column is permitted axially along the extruder barrels sections. An extruder is also disclosed. | 2011-03-24 |
20110070325 | MULTIPLE-PREFORMER DIE OF EXTRUSION MOLD FOR TIRE TREADS - Disclosed is an extrusion mold for tire treads that extrudes semi-finished tires, for example, a cap tread, a wing tread and a sub tread. The preformer includes a first preformer die-holder having a wing tread flow-path, a cap tread flow-path and a sub tread flow-path formed therein, a second preformer die-holder, and a final die inserted into the second preformer die-holder and ejecting an extrudate. The improvement of the preformer die includes a middle upper preformer die and a middle lower preformer die between the first and second preformer die-holders to be brought into contact with the final die. The middle upper preformer die is formed with a wing tread-connecting guide groove and a cap tread-connecting guide groove communicating with the wing tread flow-path and the cap tread flow-path, respectively. The middle lower preformer die is formed with a sub tread-connecting guide groove communicating with the sub tread flow-path. | 2011-03-24 |
20110070326 | OREGANO EXTRACT AND ITS COMPONENTS FOR ENHANCING VIGILANCE - Oregano extract can act as a stimulant, yet it does not interfere with sleep patterns or induce nervousness the way many stimulants such as caffeine can. It also has the benefits of promoting improved vigilance, improving attention and ability to focus on a task, and improving general alertness. | 2011-03-24 |
20110070327 | Use of High-Oleic Distillers Grains in Animal Feed to Improve Animal Product Quality - A novel method for improving the meat, milk, and egg quality of livestock is provided. In one embodiment, the method comprises feeding the animal a diet supplemented with oleic acid and distillers grains. The source of the oleic acid may be distillers grain from high-oleic corn. The method improves the quality of meat from both non-ruminants and ruminants. | 2011-03-24 |
20110070328 | Use Of Vegetable Fine Grain Sized Fibers For Preparing A Nutritional Composition For Reducing Mycotoxin Bioavailability - The invention relates to using substentially insoluble vegetable fibres embodied in the form of microparticles at least 90% in weight of which has a size less than 700 μm as ingredients for preparing a nutritional composition for reducing a mycotoxin bioavailability in a human being or an animal during ingestion of a food contaminated by said micotoxins. | 2011-03-24 |
20110070329 | 1-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds - Described is a new cooling agent represented by Formula I and compositions with known coolers having cooling properties and the application of Formula I in foodstuffs and chewing gum: | 2011-03-24 |
20110070330 | Increasing Ester Concentrations in Ethanol-Based Solutions - Systems and methods for accelerating the aging of distilled spirits are disclosed. The systems and methods may include increased reaction rates of ethanol with oxygen, acids, sugars, and/or other components within an ethanol mixture. The accelerated reactions may produce an aged alcohol in a matter of a few hours or days, whereas comparable alcohols aged conventionally would require many years. The accelerated aging of the ethanol may be performed to provide the end product with a desired flavor profile in a short period of time at a substantially reduced cost. | 2011-03-24 |
20110070331 | Accelerating Aging of Ethanol-Based Beverages - Systems and methods for accelerating the aging of distilled spirits are disclosed. The systems and methods may include increased reaction rates of ethanol with oxygen, acids, sugars, and/or other components within an ethanol mixture. The accelerated reactions may produce an aged alcohol in a matter of a few hours or days, whereas comparable alcohols aged conventionally would require many years. The accelerated aging of the ethanol may be performed to provide the end product with a desired flavor profile in a short period of time at a substantially reduced cost. | 2011-03-24 |
20110070332 | METHOD FOR PROCESSING COCOA BEANS - The present invention relates to a method for processing cocoa beans wherein fermented cocoa pulp is mixed to cocoa beans and wherein the mixture of fermented pulp with cocoa beans is further processed. The invention also relates to cocoa beans that are obtained or obtainable by methods of the present invention, to the use thereof for preparing food products, preferably chocolate products, or cocoa products, including cocoa extracts, and to food products and cocoa products, including cocoa extracts thereby obtained. | 2011-03-24 |
20110070333 | NOVEL PROCESS FOR ENZYMATIC ACRYLAMIDE REDUCTION IN FOOD PRODUCTS - The present invention relates to a novel enzyme composition comprising asparaginase and at least one hydrolysing enzyme, the use of such composition to reduce acrylamide levels in food products and a method to produce food products involving at least one heating step, comprising adding:
| 2011-03-24 |
20110070334 | Probiotic Stabilization - An ingestible composition including a probiotic contained in a mixture of hydrolyzed mammalian protein, one or more carbohydrates and a compound binder useful for nutrition of infants and children. | 2011-03-24 |
20110070335 | GRANULATED DAIRY PRODUCTS - The invention concerns a granulated dairy product that includes particles of milk powder along with dry particles selected from dried emulsified fat particles, whey protein isolates, maltodextrines, starches and sucrose or lactose powders. The milk powder and dry particles are agglomerated together and are at least partially coated with a binding medium that includes a carbohydrate to form coated agglomerate particles having a mean particle diameter of between 10 and 10000 μm. | 2011-03-24 |
20110070336 | Stabilizer System For Food And Beverage Products - A stabilizer system comprising blends of cellulose, lambda-carrageenan, and guar gum. Food products and beverages, such as energy drinks, are prepared with the stabilizer blends. | 2011-03-24 |
20110070337 | Reduced Calorie Soy Beverage - In one embodiment, a method comprises selecting ingredients including a natural, high-intensity sweetener, a dairy milk or a non-dairy milk base, and one or more other ingredients selected from the group consisting of stabilizers, vitamins, minerals, flavors, functional ingredients, salts, antioxidants, sugar, and water. The selected ingredients are added to a mixing chamber and mixed to yield a formulation with the ingredients dispersed substantially evenly throughout. | 2011-03-24 |
20110070338 | SYSTEM AND METHOD FOR FORMING A FOOD PRODUCT WITH A SOLIDIFIED LIQUID ADDITIVE - A food product includes a base component; one or more solid additive pieces, each solid additive piece comprising an additive and a binder; and a casing containing the base component and the one or more solid additive pieces; wherein the additive is a liquid at room temperature. | 2011-03-24 |
20110070339 | Batter-like compositions containing setting agent and methods of preparing and using same - The invention provides batter-like compositions including flour or a flour replacement ingredient, sweetener, a fat source, a chemical leavening system, and a setting agent. The resulting batter-like compositions are capable of being formed into discrete product pieces (such as pucks), and maintaining the puck form throughout storage and handling of the batter-like composition prior to baking. The invention further provides methods of preparing batter-like compositions having a discrete form, and methods of using such batter-like compositions to provide baked goods. | 2011-03-24 |
20110070340 | Method for Controlling at Least Two Cooking Devices, Cooking Device, and System Including at Least Two Cooking Devices - The invention relates to a method for controlling at least two cooking devices, an associated cooking device and an associated system consisting of at least two cooking devices. According to the invention, data is generated in a control unit of at least one cooking device, said data being suitable for influencing the operation of another cooking device. The data is transmitted to a control unit ( | 2011-03-24 |
20110070341 | DEVICE AND METHOD FOR THE HIGH-PRESSURE TREATMENT OF PRODUCTS - The present disclosure relates to a device for the high-pressure treatment of products, particularly of packaged foodstuffs. The device comprises a high-pressure chamber and a discharge valve for discharging high-pressure medium out of the high-pressure chamber. The invention is characterized in that a controllable actuator is provided for adjusting the rate of the pressure decrease in the high-pressure chamber at least over a predetermined pressure range. The disclosure also relates to a method for the high-pressure treatment of products, wherein pressure decrease takes place in a first phase and in a second phase, and the mean pressure decrease rate in the first phase is higher than in the second phase. | 2011-03-24 |
20110070342 | Method for evaluating and orientating baked product | 2011-03-24 |
20110070343 | Canola protein product from supernatant - A novel canola protein product consisting predominantly of 2S canola protein and having improved solubility properties, has an increased proportion of 2S canola protein and a decreased proportion of 7S canola protein, and a protein content of less than about 90 wt % (N×6.25) d.b. The novel canola protein isolate is formed by heat treatment or isoelectric precipitation of aqueous supernatant from canola protein micelle formation and precipitation, to effect precipitation of 7S protein which is sedimented and removed. | 2011-03-24 |
20110070344 | Tandem Use of Catholyte and Anolyte to Clean and Sanitize Fruit and Vegetables - A method for de-soiling and disinfecting produce, the method including: treating the produce with a catholyte solution to yield a catholyte treated produce; sonicating the catholyte treated produce to yield a sonicated produce; and treating the sonicated produce with an anolyte solution. | 2011-03-24 |
20110070345 | Flavor Infusion Device for Roasting Poultry - A flavor infusion device for roasting poultry, such as chicken, comprising an elongated metal member having an attachment means at one end for attachment to a sidewall of a roasting pan, a radiused bent portion extending upwardly from the attachment means, and a horizontal arm portion extending from the radiused bent portion in a substantially horizontal orientation relative to the roasting pan to support an open cavity of the poultry, said horizontal arm portion having a flavor cup associated therewith for receiving an infusion flavoring liquid therein. A method of roasting poultry comprising the steps of providing a flavor infusion device, attaching the device to a sidewall of a roasting pan, placing an infusion liquid in the cup, mounting the poultry on the horizontal arm of the device, preferably in a breast-down orientation, and roasting the poultry. | 2011-03-24 |
20110070346 | INTEGRAL INTERVENTION SYSTEM - An intervention system for treating a food product in a food conditioner. The system comprises a tank that receives and buffers an intervention solution from a mixing system, a pump that receives the intervention solution from the tank and pressurizes the intervention solution to output a pressurized intervention solution, a flow monitor that receives the pressurized intervention solution from the pump and monitors a predetermined characteristic of the pressurized intervention solution, a first applicator that receives a first portion of the pressurized intervention solution from the flow monitor and ejects a first mist in the direction of the food product, and a second applicator that receives a second portion of the pressurized intervention solution from the flow monitor and ejects a second mist in the direction of the food product. | 2011-03-24 |
20110070347 | COMPOSITION FOR BLOCKING INTERFIBRILLAR SPACES IN MEAT AND MEAT TREATMENT METHODS USING SAID COMPOSITION - The invention relates to a gluten-free composition that acts as an agent for blocking interfibrillar spaces in meat tissue and to a method for forming a ‘cover’ which, during cooking, provides an increase in the vapour pressure inside the fillet or piece of meat and, consequently, in the temperature inside same, thereby reducing both cooking time and meat juice loss, which increases the mass yield, juiciness and flavour characteristic of meat at the end of the cooking process. In addition, the invention relates to methods for treating meat with said composition prior to cooking. | 2011-03-24 |
20110070348 | Beverage Preparation Machines And Methods For Operating Beverage Preparation Machines - A method of operating a beverage preparation machine, the beverage preparation machine being of the type comprising a brewer comprising: a reservoir containing water; a delivery head for receiving in use a cartridge containing one or more beverage ingredients; a pump for pumping water from said reservoir to said delivery head; a primary heater for heating the water contained in said reservoir; a secondary heater in between the reservoir and the delivery head; a controller for controlling energisation of the primary heater and the secondary heater; and wherein the controller operates to prevent energisation of the primary heater simultaneous with energisation of the secondary heater. An apparatus for carrying out the method is also disclosed and methods and apparatus utilising first and second brewers. | 2011-03-24 |
20110070349 | DEVICE AND METHOD FOR FOAMING A LIQUID FOODSTUFF, ESPECIALLY MILK - A device for foaming a liquid foodstuff, especially milk, is provided including a pump ( | 2011-03-24 |
20110070350 | Matcha green tea konnyaku noodle and method of preparing thereof - Disclosed is a matcha (finely-powdered green tea) green tea konnyaku (konjac) noodle (shirataki) and a method of preparing thereof. | 2011-03-24 |
20110070351 | FOOD SUPPLEMENT - The invention relates to food supplements comprising silica a quaternary ammonium compound or a group Ia hydroxide and an organic acid, and to those comprising a group Ia silicon salt and an organic acid, to methods of making such supplements and to foods containing them. | 2011-03-24 |
20110070352 | WHEAT WITH ALTERED BRANCHING ENZYME ACTIVITY AND STARCH AND STARCH CONTAINING PRODUCTS DERIVED THEREFROM - Wheat having a reduced level of SBEIIa activity, that may have a relative high amylose content. Wheat having a mutant SBEIIa gene in the A genome. The wheat might additionally have reduced levels of SBEIIb activity. The wheat grain of this invention can be of a non-shrunken phenotype despite a lesion in the amylopectin synthesis pathway, and may also have a high relative amylose content. | 2011-03-24 |
20110070353 | METHOD FOR SHUCKING LOBSTER, CRAB OR SHRIMP - A method for facilitating the removal of the shell of a lobster, crab or shrimp by exposing the lobster, crab or shrimp to pressure for a period of time sufficient to effect detachment of the meat from the shell. Following pressurization, the shell can be easily removed using any available means to provide deshelled raw lobster, crab or shrimp meat. | 2011-03-24 |
20110070354 | Instantized whey protein concentrate/isolate with egg lecithin - A liquid soluble protein drink comprised of whey protein concentrate or whey protein isolate in combination with egg lecithin which results in a protein supplement wherein the whey protein concentrate is 80% protein and the whey protein isolate is 90% protein when combined with egg lecithin and eliminating phytosterols. | 2011-03-24 |
20110070355 | POLYMERIC MARKER WITH HIGH RADIOPACITY FOR USE IN MEDICAL DEVICES - High radiopacity is achieved in a polymeric marker by combining a polymeric resin, a powdered radiopaque agent having uniformly shaped particles of a specific particle size distribution and a wetting agent. The method to produce the marker calls for the blending and pelletization of these materials followed by extrusion onto support beading. The resulting supported tubing is subsequently cut to length with the beading still in place. After ejection of the beading remnant the marker is slipped into place on the device to be marked and attached by melt bonding. Marking of a guidewire allows lesions to be measured while the marking of balloon catheters allow the balloon to be properly positioned relative to a lesion. | 2011-03-24 |
20110070356 | Texturizing Surfaces - Methods for applying surface texture to the exterior of bodily implants, as well as implants made by the methods described. | 2011-03-24 |
20110070357 | Apparatus and Methods for Loading a Drug Eluting Medical Device - Methods and apparatus are disclosed for loading a therapeutic substance or drug within a lumenal space of a hollow wire having a plurality of side openings along a length thereof that forms a hollow drug-eluting stent with a plurality of side drug delivery openings. Loading a drug within the lumenal space of the hollow stent includes a drug filling step, in which the drug is mixed with a solvent or dispersion medium. The lumenal space may be filled with the drug solution or suspension in a reverse fill process and/or a forward fill process. After the drug filling step, a solvent or dispersion medium extracting step is performed to extract the solvent or dispersion medium from within the lumenal space such that only the drug remains within the hollow stent. A stent cleaning step may be performed to an exterior surface of the hollow stent. | 2011-03-24 |
20110070358 | Method of forming hollow tubular drug eluting medical devices - A method of a forming a hollow, drug-eluting medical device includes utilizing a hollow wire having an outer member and a lumen of the outer member, and filling the lumen with a fluid to form a supported hollow wire. The supported hollow wire is shaped into a stent pattern. Openings are formed through the outer member. The supported hollow wire is processed to remove the fluid from the lumen of the outer member without adversely affecting the outer member, leaving the hollow wire shaped into a stent pattern. The lumen is filled with a biologically or pharmacologically active substance. | 2011-03-24 |
20110070359 | FILM FORMATION METHOD AND FILM FORMATION APPARATUS - A film formation method according to the present invention includes the step of forming a film of material powders | 2011-03-24 |
20110070360 | SOURCE GAS SUPPLY UNIT, AND DEPOSITION APPARATUS AND METHOD USING THE SAME - Provided are a source gas supply unit capable of supplying a constant amount of source gas to a deposition chamber to deposit a uniform layer, and a deposition apparatus and method using the same. The source gas supply unit includes a canister in which a source is stored, a heater heating the canister, a source gas supply pipe provided on one side of the canister, a measuring unit installed on the source gas supply pipe and measuring an amount of source gas passing through the source gas supply pipe, and a temperature controller connected to the heater and the measuring unit. The temperature controller controls the heater based on the amount of the source gas measured by the measuring unit. | 2011-03-24 |
20110070361 | NON-ELECTROLYTIC DEPOSITION METHOD - The invention relates to a method for the non-electrolytic deposition of a compound, preferably an electrochromic compound, comprising the following successive steps: (a) an electroconductive layer is deposited on a non-conductive solid substrate; (b) a reducing agent or an oxidizing agent (=redox agent) is deposited on an area of said electroconductive layer, said area covering only a portion of the surface of said electroconductive layer; and (c) a solution of a precursor of the compound to be deposited is brought into contact both with the redox agent and with at least a portion of the area of said electroconductive layer not covered by the redox agent, said precursor being chosen from those having an oxidation-reduction potential higher or lower than the redox agent and forming, after an oxidation-reduction reaction, a compound insoluble in the solution of the precursor of the compound to be deposited. | 2011-03-24 |
20110070362 | BATTERY ELECTRODE SUBSTRATE, AND ELECTRODE EMPLOYING THE SAME - An electrode substrate for a battery has nickel applied as a coat on the surface of a base constituted of crossing of a plurality of fibers including a core formed of synthetic resin and a coating of synthetic resin having a softening temperature lower than the softening temperature of the synthetic resin forming the core. The electrode substrate has the fibers of the base fusion-bonded at a cross point by heat treatment. The ratio of the coating occupying a II-II cross section of the fiber cross point is larger than the ratio of the coating occupying a fiber cross section (III-III cross section) at a site other than at the cross point. | 2011-03-24 |
20110070363 | PROCESS FOR PRODUCTION OF WATER-RESISTANT ORGANIC THIN FILM - There is provided a process for production of a water-resistant organic thin film without causing damage to the water-resistant organic thin film which comprises the steps of: (a) keeping supporting means away from an organic thin film; (b) preventing a base material on which the organic thin film is laminated from warping; and (c) allowing the base material on which the organic thin film is laminated to gently pass through a water-resistant treatment liquid in a reactor. | 2011-03-24 |
20110070364 | METHOD FOR HOLDING A LENS FOR DIP TREATMENT THEREOF - Method for dip treatment of an optical element, wherein the optical element is held, while it is being dipped, by a holding ring, the ring including a hoop for draining and encircling a peripheral edge of the optical element, thereby exerting continuous linear contact with the peripheral edge, the hoop forming an arc over more than 180° and being provided at each of its two ends with an outwardly-directed drip tab pointing away from the optical element. | 2011-03-24 |
20110070365 | METHOD FOR MANUFACTURING FILM-FORMED BODY - Provided is a method for manufacturing a film-formed body wherein a second film is formed by suppressing influence of existence/absence of a first film, at the time of forming the second film by making fine particles collide and deposited on a second film forming surface on a substrate whereupon the first film has been already formed. A film-formed body is provided with a foil-like substrate having a first film-forming surface and a second film-forming surface; a first film formed on a part of the first film-forming surface; and a second film formed at least on a part of the second film-forming surface. The first film includes an overlapping section which overlaps with the second film when viewed in the thickness direction of the substrate. A method for manufacturing such film-formed body is provided with a second film-forming step of forming the second film on the second film-forming surface whereupon the first film has been formed, by making the fine particles collide and deposited on the second film-forming surface, by using a supporting member having a supporting surface and a recessed section depressed from the supporting surface. | 2011-03-24 |